AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9699399 — intervention group
Group type: COMPARATOR
Intervention: Normal tissues (no contact with magnets)
Number of subjects: 8
Study 9699399 — intervention group
Group type: COMPARATOR
Intervention: Control and test sites (both)
Number of subjects: 8
Study 7978420 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mg/kg droperidol (Group 1, n = 10)
Number of subjects: 40
Study 7978420 — intervention group
Group type: COMPARATOR
Intervention: 0.175 mg/kg droperidol (Group 2, n = 10)
Number of subjects: 40
Study 7978420 — intervention group
Group type: COMPARATOR
Intervention: 0.25 mg/kg droperidol (Group 3, n = 20)
Number of subjects: 40
Study 2532459 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg
Number of subjects: 169
Study 2532459 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 169
Study 2532459 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 5 mg
Number of subjects: 169
Study 2532459 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 50 mg
Number of subjects: 169
Study 2532459 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 169
Study 2532459 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 169
Study 954730 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill running at 140 m/min for durations ranging from 0.5 to 20 min
Number of subjects: 30
Study 31612337 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Reports (SR)
Number of subjects: 24
Study 31612337 — intervention group
Group type: COMPARATOR
Intervention: Free Text Reports (FTR)
Number of subjects: 24
Study 30580672 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy and treadmill training
Number of subjects: 30
Study 30580672 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention (no mirror visual feedback)
Number of subjects: 30
Study 26095747 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.197% with adjunct dexmedetomidine 0.3 μg·kg(‐1) (Group LAD)
Number of subjects: 43
Study 26095747 — intervention group
Group type: COMPARATOR
Intervention: Plain ropivacaine 0.197% (Group LA)
Number of subjects: 43
Study 23740321 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine + epinephrine 1:100,000
Number of subjects: 10
Study 23740321 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine + epinephrine 1:200,000
Number of subjects: 10
Study 23740321 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine + epinephrine 1:300,000
Number of subjects: 10
Study 23740321 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine + epinephrine 1:400,000
Number of subjects: 10
Study 23740321 — intervention group
Group type: COMPARATOR
Intervention: 4% articaine without epinephrine
Number of subjects: 10
Study 21733144 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighing
Number of subjects: 51
Study 21733144 — intervention group
Group type: EXPERIMENTAL
Intervention: Household measures
Number of subjects: 51
Study 21733144 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital photographs
Number of subjects: 51
Study 19446149 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 50 mg with high-fat, high-calcium breakfast
Number of subjects: 44
Study 19446149 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 75 mg with low-fat, low-calcium meal
Number of subjects: 44
Study 19446149 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 75 mg with high-fat, low-calcium meal
Number of subjects: 44
Study 19446149 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 75 mg with antacid containing aluminum hydroxide and magnesium carbonate
Number of subjects: 44
Study 19446149 — intervention group
Group type: COMPARATOR
Intervention: Control group (fasted state)
Number of subjects: 44
Study 17332105 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise program for twelve weeks
Number of subjects: 40
Study 17332105 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation protocol
Number of subjects: 40
Study 15247109 — intervention group
Group type: EXPERIMENTAL
Intervention: i.m. ketamine 1 mg kg(‐1) in 2 ml plus epidural normal saline
Number of subjects: 60
Study 15247109 — intervention group
Group type: EXPERIMENTAL
Intervention: epidural ketamine 1 mg kg(‐1) in 10 ml plus i.m. normal saline
Number of subjects: 60
Study 15247109 — intervention group
Group type: COMPARATOR
Intervention: epidural normal saline 10 ml plus i.m. normal saline 10 ml
Number of subjects: 60
Study 11793630 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 257
Study 9471042 — intervention group
Group type: EXPERIMENTAL
Intervention: Da Capo home flowmeter
Number of subjects: 10
Study 9471042 — intervention group
Group type: COMPARATOR
Intervention: Urodyn 1000 flowmeter
Number of subjects: 10
Study 7604698 — intervention group
Group type: EXPERIMENTAL
Intervention: Boneloc cement
Number of subjects: 30
Study 7604698 — intervention group
Group type: COMPARATOR
Intervention: Palacos cement
Number of subjects: 30
Study 2297507 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh cultured epithelial allografts
Number of subjects: 20
Study 2297507 — intervention group
Group type: COMPARATOR
Intervention: Cryopreserved cultured epithelial allografts
Number of subjects: 20
Study 314787 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal splenorenal (Warren) shunt
Number of subjects: 0
Study 314787 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesocaval shunt
Number of subjects: 0
Study 31258054 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 20
Study 31258054 — intervention group
Group type: COMPARATOR
Intervention: Control (no kinesio taping)
Number of subjects: 20
Study 30810382 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly 50 mg of transdermal testosterone plus daily oral 1 mg estradiol valerate for 8 weeks
Number of subjects: 70
Study 30810382 — intervention group
Group type: COMPARATOR
Intervention: Only estrogen for 8 weeks
Number of subjects: 70
Study 28430890 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-formed retainers (VFRs)
Number of subjects: 86
Study 28430890 — intervention group
Group type: COMPARATOR
Intervention: Hawley retainers (HRs)
Number of subjects: 86
Study 28430890 — intervention group
Group type: EXPERIMENTAL
Intervention: Both retainers (HR and VFR)
Number of subjects: 86
Study 25783154 — intervention group
Group type: EXPERIMENTAL
Intervention: NCPAP cycling (Group A: cycling between NCPAP of 4 cm and 1 liter per minute (LPM) of nasal prongs)
Number of subjects: 30
Study 25783154 — intervention group
Group type: COMPARATOR
Intervention: Continuous NCPAP (Group B: continuous NCPAP at 4 cm of H2O)
Number of subjects: 30
Study 25115430 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (30 mg/kg)
Number of subjects: 153
Study 25115430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 22228446 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib (400 mg bid)
Number of subjects: 451
Study 18346869 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory Anchor
Number of subjects: 40
Study 18346869 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Textual/Auditory Anchors
Number of subjects: 40
Study 18346869 — intervention group
Group type: EXPERIMENTAL
Intervention: Textual Anchor
Number of subjects: 40
Study 18346869 — intervention group
Group type: COMPARATOR
Intervention: No Anchor
Number of subjects: 40
Study 17598719 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 64
Study 17598719 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 64
Study 17598719 — intervention group
Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 64
Study 15237706 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin gene pattern risk scores (summed risk score from two single nucleotide polymorphisms: -23 Hph I; +1127 Pst I)
Number of subjects: 158
Study 11904741 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of parenteral iron
Number of subjects: 33
Study 11904741 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injections of parenteral iron
Number of subjects: 33
Study 9559452 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit weight training (CWT) at 40% 1-RM with 60 seconds rest
Number of subjects: 9
Study 9559452 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit weight training (CWT) at 40% 1-RM with 30 seconds rest
Number of subjects: 9
Study 9559452 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit weight training (CWT) at 60% 1-RM with 60 seconds rest
Number of subjects: 9
Study 9559452 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit weight training (CWT) at 60% 1-RM with 30 seconds rest
Number of subjects: 9
Study 9559452 — intervention group
Group type: COMPARATOR
Intervention: Treadmill exercise at 85% of VO2max
Number of subjects: 9
Study 7655179 — intervention group
Group type: EXPERIMENTAL
Intervention: sCT 100 IU daily
Number of subjects: 40
Study 7655179 — intervention group
Group type: EXPERIMENTAL
Intervention: sCT 200 IU daily
Number of subjects: 40
Study 7655179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2744068 — intervention group
Group type: EXPERIMENTAL
Intervention: Witepsol H12 suppositories containing 75 mg, 100 mg, and 150 mg of meptazinol
Number of subjects: 15
Study 2744068 — intervention group
Group type: COMPARATOR
Intervention: 200 mg oral tablet of meptazinol
Number of subjects: 15
Study 2744068 — intervention group
Group type: EXPERIMENTAL
Intervention: Witepsol H12 suppositories (all doses)
Number of subjects: 15
Study 76752 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-phosphatase reaction in T-A.L.L.
Number of subjects: 148
Study 76752 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-phosphatase reaction in common-A.L.L.
Number of subjects: 148
Study 76752 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-phosphatase reaction in null-A.L.L.
Number of subjects: 148
Study 30321078 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30
Study 30321078 — intervention group
Group type: COMPARATOR
Intervention: Microneedling
Number of subjects: 30
Study 27918916 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced optimism condition (practiced making optimistic future-event predictions)
Number of subjects: 170
Study 27918916 — intervention group
Group type: COMPARATOR
Intervention: Control condition (viewed stimuli and practiced determining if a phrase contained an adjective)
Number of subjects: 170
Study 25952257 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 4465
Study 25952257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4465
Study 22906516 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day, n = 34)
Number of subjects: 74
Study 22906516 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 40)
Number of subjects: 74
Study 22906516 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day) in normal DβH level genotype
Number of subjects: 74
Study 22906516 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day) in low DβH level genotype
Number of subjects: 74
Study 21266648 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the smartphone with short teleconsultations every 2 weeks (G3)
Number of subjects: 180
Study 21266648 — intervention group
Group type: EXPERIMENTAL
Intervention: Home use of a smartphone recommending insulin doses with quarterly visits (G2)
Number of subjects: 180
Study 21266648 — intervention group
Group type: COMPARATOR
Intervention: Usual quarterly follow-up (G1)
Number of subjects: 180
Study 21266648 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabeo system (G3)
Number of subjects: 180
Study 19856688 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.25% bupivacaine (2 mL/h) plus intravenous analgesics
Number of subjects: 26
Study 19856688 — intervention group
Group type: COMPARATOR
Intervention: Intravenous analgesics only (control group)
Number of subjects: 26
Study 17112805 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose
Number of subjects: 60
Study 16792649 — intervention group
Group type: EXPERIMENTAL
Intervention: New device for nail trephination using mesoscission technology
Number of subjects: 14
Study 16792649 — intervention group
Group type: EXPERIMENTAL
Intervention: New device for nail trephination
Number of subjects: 14
Study 12693490 — intervention group
Group type: EXPERIMENTAL
Intervention: Overdrive biatrial pacing
Number of subjects: 776
Study 12693490 — intervention group
Group type: EXPERIMENTAL
Intervention: Overdrive right atrial pacing
Number of subjects: 776
Study 12693490 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed high-rate biatrial pacing
Number of subjects: 776
Study 12693490 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed high-rate right atrial pacing
Number of subjects: 776
Study 12693490 — intervention group
Group type: COMPARATOR
Intervention: Overdrive left atrial pacing
Number of subjects: 776
Study 10376178 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 38
Study 10376178 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 38
Study 8721527 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute allergen challenge (increasing doses every 15 min until symptoms occurred) in 9 patients.
Number of subjects: 19
Study 8721527 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated low-dose allergen exposure (one small dose daily for 7 days) in 10 patients.
Number of subjects: 19
Study 8721527 — intervention group
Group type: COMPARATOR
Intervention: Control group (4 patients challenged with diluent only).
Number of subjects: 19
Study 1839557 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettage with hydrocolloid occlusion
Number of subjects: 30
Study 1839557 — intervention group
Group type: COMPARATOR
Intervention: Curettage alone
Number of subjects: 30
Study 6849206 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin gluceptate
Number of subjects: 98
Study 6849206 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 98
Study 6849206 — intervention group
Group type: COMPARATOR
Intervention: Overall
Number of subjects: 98
Study 29096934 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing sessions at baseline, 3, 6, and 12 months, in addition to a brief physician recommendation to increase physical activity.
Number of subjects: 340
Study 29096934 — intervention group
Group type: COMPARATOR
Intervention: Brief physician recommendation to increase physical activity to meet national guidelines.
Number of subjects: 340
Study 28441975 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance abuse treatment
Number of subjects: 641
Study 28441975 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use at last sex
Number of subjects: 641
Study 28441975 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical assault in the past year
Number of subjects: 641
Study 28441975 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive urine test for opiates or cocaine
Number of subjects: 641
Study 26607061 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant massage
Number of subjects: 56
Study 26607061 — intervention group
Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 56
Study 22014414 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children
Number of subjects: 91
Study 22014414 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight children
Number of subjects: 91
Study 22014414 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese and overweight children
Number of subjects: 91
Study 22014414 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese group
Number of subjects: 91
Study 21041707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (PSA screening)
Number of subjects: 73678
Study 21041707 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 73678
Study 18251647 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (removal of granulation tissue and soft microbial deposits by cleaning the root surface with a microbrush and saline solution, aiming at cementum preservation)
Number of subjects: 30
Study 18251647 — intervention group
Group type: COMPARATOR
Intervention: Control group (scaling and root planing with removal of granulation tissue and root cementum)
Number of subjects: 30
Study 16737375 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit disposition to approach goals
Number of subjects: 0
Study 16737375 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit disposition to avoid temptations
Number of subjects: 0
Study 16737375 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-control conflict magnitude
Number of subjects: 0
Study 16737375 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful self-control
Number of subjects: 0
Study 15298244 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral balance gel
Number of subjects: 39
Study 15298244 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 39
Study 11151741 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine ER 5 mg and Metoprolol CR/ZOC 50 mg (free combination)
Number of subjects: 26
Study 11151741 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine ER 5 mg and Metoprolol CR/ZOC 50 mg (fixed combination)
Number of subjects: 26
Study 11151741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 9727214 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT) model
Number of subjects: 0
Study 9727214 — intervention group
Group type: COMPARATOR
Intervention: Blended ACT principles with the Rhinelander model
Number of subjects: 0
Study 8360369 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation treatment
Number of subjects: 70
Study 8360369 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation+efficacy-enhancement treatment
Number of subjects: 70
Study 8360369 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation-only condition
Number of subjects: 70
Study 8360369 — intervention group
Group type: COMPARATOR
Intervention: Standard preparation
Number of subjects: 70
Study 8360369 — intervention group
Group type: COMPARATOR
Intervention: Oral premedication
Number of subjects: 70
Study 3526884 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 60
Study 3526884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 28161142 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 38
Study 26938752 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTL)
Number of subjects: 60
Study 24622930 — intervention group
Group type: EXPERIMENTAL
Intervention: RVA pacing
Number of subjects: 164
Study 24622930 — intervention group
Group type: COMPARATOR
Intervention: RVOT pacing
Number of subjects: 164
Study 24622930 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 164
Study 22017318 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Massage (TM)
Number of subjects: 44
Study 22017318 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Movement (PM)
Number of subjects: 44
Study 22017318 — intervention group
Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 44
Study 19939873 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) in dim light
Number of subjects: 30
Study 19939873 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light after acute tryptophan depletion (ATD)
Number of subjects: 30
Study 19939873 — intervention group
Group type: COMPARATOR
Intervention: Dim light with balanced amino acid mixtures
Number of subjects: 30
Study 19939873 — intervention group
Group type: COMPARATOR
Intervention: Bright light with balanced amino acid mixtures
Number of subjects: 30
Study 18416476 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fish oil and soybean oil (LCT:fish oil = 5:1, Omegaven, Fresenius-Kabi)
Number of subjects: 42
Study 18416476 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil (LCT; Intralipid, Fresenius-Kabi)
Number of subjects: 42
Study 16030279 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg IV, 4 doses: 2 intraoperative and 2 postoperative)
Number of subjects: 295
Study 16030279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295
Study 16030279 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg IV)
Number of subjects: 295
Study 14622076 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential treatment for depression (16-20 sessions)
Number of subjects: 34
Study 11079877 — intervention group
Group type: EXPERIMENTAL
Intervention: Concept Based Indexing using SNOMED‐RT
Number of subjects: 100
Study 11079877 — intervention group
Group type: COMPARATOR
Intervention: Keyword Indexing
Number of subjects: 100
Study 8964866 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH therapy (4 IU/m2.day, sc)
Number of subjects: 30
Study 8964866 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (10 subjects with NS)
Number of subjects: 30
Study 1804652 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal (IN) administration of midazolam 0.2 mg.kg‐1
Number of subjects: 12
Study 1804652 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) administration of midazolam 0.2 mg.kg‐1
Number of subjects: 12
Study 6402201 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.15 mg)
Number of subjects: 40
Study 6402201 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol (50 mg)
Number of subjects: 40
Study 6402201 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (5 mg)
Number of subjects: 40
Study 6402201 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine (50 mg)
Number of subjects: 40
Study 6402201 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular analgesic system
Number of subjects: 40
Study 6402201 — intervention group
Group type: COMPARATOR
Intervention: Intravenous on demand systems
Number of subjects: 40
Study 30858255 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 246
Study 30858255 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP training
Number of subjects: 246
Study 30858255 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication training
Number of subjects: 246